Mokale Santosh N, Begum Afreen, Sakle Nikhil S, Shelke Vishakha R, Bhavale Swati A
Dr. Rafiq Zakaria Campus, Y.B. Chavan College of Pharmacy, Aurangabad 431001, Maharashtra, India.
Dr. Rafiq Zakaria Campus, Y.B. Chavan College of Pharmacy, Aurangabad 431001, Maharashtra, India.
Biomed Pharmacother. 2017 May;89:966-972. doi: 10.1016/j.biopha.2017.02.089. Epub 2017 Mar 9.
By utilizing concept of molecular hybridization, involving combination of various Pharmacophore, novel substituted coumarin-chalcone hybrids was synthesized and evaluated for anti-proliferative activity against estrogen receptor-positive MCF-7 and negative MDA-MB-435 breast cancer cell lines. In-vivo study was carried out by N-methyl nitrosourea (MNU) induced mammary carcinoma in virgin female Spraque Dawly (SD) rats. The compound 5b has highest potential than standard drug Adriamycin, comparable against Tamoxifen against ER-positive MCF-7 breast cancer cell lines. Docking study was performed to study the binding orientation and affinity of synthesized compounds on the ER-α enzyme.
通过利用分子杂交的概念,涉及各种药效团的组合,合成了新型取代香豆素-查尔酮杂化物,并评估了其对雌激素受体阳性MCF-7和阴性MDA-MB-435乳腺癌细胞系的抗增殖活性。通过N-甲基亚硝基脲(MNU)诱导处女雌性斯普拉格-道利(SD)大鼠发生乳腺癌进行体内研究。化合物5b比标准药物阿霉素具有更高的潜力,在抗雌激素受体阳性MCF-7乳腺癌细胞系方面与他莫昔芬相当。进行对接研究以研究合成化合物在雌激素受体-α酶上的结合方向和亲和力。